Clari Vest Asset Management LLC Macrogenics Inc Transaction History

Clari Vest Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$9.77 - $21.47 $673,426 - $1.48 Million	-68,928 Reduced 36.89%	117,919 $1.74 Million
Q4 2023 Feb 13, 2024	BUY	$4.48 - $10.11 $399,826 - $902,287	89,247 Added 91.44%	186,847 $1.8 Million
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $450,912 - $735,904	97,600 New	97,600 $522,000
Q2 2020 Aug 12, 2020	SELL	$5.2 - $29.12 $193,960 - $1.09 Million	-37,300 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$4.28 - $12.11 $10,272 - $29,064	-2,400 Reduced 6.05%	37,300 $217,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $12.27 $138,330 - $213,498	17,400 Added 78.03%	39,700 $432,000
Q3 2019 Nov 12, 2019	SELL	$12.44 - $17.48 $3,732 - $5,244	-300 Reduced 1.33%	22,300 $284,000
Q2 2019 Aug 16, 2019	BUY	$14.51 - $19.71 $53,687 - $72,927	3,700 Added 19.58%	22,600 $384,000
Q1 2019 May 13, 2019	BUY	$11.11 - $25.6 $209,979 - $483,840	18,900 New	18,900 $340,000

131

56M

28.3K

197K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $143M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.